找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Gene Therapy; David T. Curiel,Joanne T. Douglas Book 2005 Humana Press 2005 cancer treatment.clinical trial.gene therapy.gene trans

[復(fù)制鏈接]
51#
發(fā)表于 2025-3-30 11:08:49 | 只看該作者
52#
發(fā)表于 2025-3-30 13:50:15 | 只看該作者
53#
發(fā)表于 2025-3-30 18:49:27 | 只看該作者
A. Bonso,A. Rossillo,R. Valente,A. Ravieleto the bedside. Between 1994 and the end of 2002, more than 25 clinical trials for TSG replacement therapy were initiated, and results indicated a promising future for TSG in the management of cancer.
54#
發(fā)表于 2025-3-30 21:28:27 | 只看該作者
New Advances in Histamine Researchnuclear (sn)RNAs as a ribozyme in complex with the premessenger RNA (pre-mRNA) to catalyze pre-mRNA splicing has also been proposed .. It is highly likely that additional RNA catalytic motifs and new roles for RNA-mediated catalysis will also be found as more is learned about the genomes of a variet
55#
發(fā)表于 2025-3-31 02:21:02 | 只看該作者
Book 2005cancer genes and gene delivery methods currently available for cancer gene therapy, including the transfer of genetic material into the cancer cells, stimulation of the immune system to recognize and eliminate cancer cells, and the targeting of the nonmalignant stromal cells that support their growt
56#
發(fā)表于 2025-3-31 06:57:48 | 只看該作者
57#
發(fā)表于 2025-3-31 11:14:32 | 只看該作者
58#
發(fā)表于 2025-3-31 14:09:43 | 只看該作者
59#
發(fā)表于 2025-3-31 20:06:07 | 只看該作者
https://doi.org/10.1007/978-88-470-2087-0 technologies in this field. For the purpose of this chapter, we use . to refer to the classical antisense approach. Other chapters in this book provide further information and discussions on ribozyme and aptamer approaches (. Chapter 5).
60#
發(fā)表于 2025-4-1 00:57:35 | 只看該作者
Antiphospholipid Syndrome Risk Evaluationnatives aimed at enhancing the selectivity of cancer chemotherapy for solid tumors rely on targeting cancer cells with chemoimmunoconjugates, antibody-directed enzyme prodrug therapy (ADEPT) ., or gene-directed enzyme prodrug therapy (GDEPT) ..
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 07:44
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
买车| 上思县| 泸州市| 襄垣县| 同江市| 郁南县| 尼玛县| 晴隆县| 小金县| 宁化县| 宜丰县| 斗六市| 汾阳市| 治县。| 如东县| 景洪市| 革吉县| 铅山县| 凤冈县| 芜湖县| 库尔勒市| 安阳县| 沧州市| 长宁区| 澄城县| 化德县| 许昌县| 略阳县| 迁安市| 安新县| 新安县| 醴陵市| 化州市| 天等县| 木里| 正定县| 任丘市| 喀什市| 景宁| 高阳县| 凉山|